By Memorandum Order entered by The Honorable Colm F. Connolly in Pharmacyclics LLC et al. v. Cipla Limited, et al., Civil Action No. 18-192-CFC/CJB (D.Del. November 10, 2020) (Consolidated), the Court granted Plaintiffs’ request to preclude Defendant Sandoz from maintaining its theory that U.S. Patent No. 10,106,548 (“the ‘548 patent”) is invalid

By Memorandum Order entered by The Honorable Sue L. Robinson in Intellectual Ventures I LLC, et al. v. Toshiba Corp., et al., Civil Action No. 13-453-SLR (D.Del. September 7, 2016), the Court granted defendants’ motion to amend their answer to include a defense of improper inventorship with respect to U.S. Patent No. 5,938,742 (“the